NCT06636227View on ClinicalTrials.gov

Diclofenac Dose Response Study

PHASE1RecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions

Alcohol Use Disorder (AUD)Alcohol-Related Disorders

Interventions

DRUG

Diclofenac 100mg

Diclofenac 100mg

DRUG

Diclofenac 75mg

Diclofenac 75mg

DRUG

Diclofenac 50mg

Diclofenac 50mg

DRUG

Placebo control

Placebo control

Trial Locations (1)

21248

RECRUITING

Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER